Akèy › Kansè Poumon ki pa ti selil › Vermont › Burlington
Etid klinik pou Kansè Poumon ki pa ti selil nan Burlington, VT
4 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Burlington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- University of Vermont Medical Center, Burlington
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- The University of Vermont Medical Center Inc., Burlington
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- The University of Vermont Medical Center Inc., Burlington
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Burlington
- Ensifizyans kadyak8 etid
- Leksemi mieloïd egi7 etid
- Kansè (tout kalite)6 etid
- BPCO5 etid
- Kansè nan tete5 etid
- Leukemi4 etid
- Maladi Parkinson4 etid
- Kansè poumon4 etid
- Maladi kadyovaskilè4 etid
- Fibroz sistik4 etid
- Kansè pwostat4 etid
- Kansè Metastatik4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.